Skip to content

Study · Not a test of the peptide alone · 2013

1 result

Imparting regenerative capacity to limbs by progenitor cell transplantation.

Lin G, Chen Y, Slack JM

Developmental cell27 Dec 2012Cited by 60 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01AnimalNot a test of Thymosin beta-4 (human) aloneAnimal study (in vivo)Efficacy outcome

    In frogs, transplanting larval limb progenitor cells with Wnt/β-catenin activation plus Sonic hedgehog, FGF10 and thymosin β4 allowed multidigit regenerates.

    In plain wordsIn frogs, transplanted limb cells treated with several factors, including thymosin β4, let limbs regrow with several digits. Thymosin β4 alone was not tested.

    Outcome
    IncreaseMultidigit limb regenerate formation
    Study

    Xenopus frogn: not reported in source

    limb regeneration after progenitor cell transplantation
    Outcome group
    Wound healing · Musculoskeletal

    Source sentences

    Summary
    Here, we show that frog limbs can be caused to form multidigit regenerates after receiving transplants of larval limb progenitor cells. It is necessary to activate Wnt/β-catenin signaling in the cells and to add Sonic hedgehog, FGF10, and thymosin β4.
    1 context sentence
    Summary · context
    The frog Xenopus can normally regenerate its limbs at early developmental stages but loses the ability during metamorphosis.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.